Healthcare - Biotechnology - NASDAQ - US
$ 6.12
-3.32 %
$ 647 M
Market Cap
-5.06
P/E
BALANCE SHEET
298 M
ASSETS
47.1 M
LIABILITIES
251 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Annexon, Inc.
| Current Assets | 264 M |
| Cash & Short-Term Investments | 260 M |
| Receivables | 0 |
| Other Current Assets | 4.14 M |
| Non-Current Assets | 33.8 M |
| Long-Term Investments | 0 |
| PP&E | 32.8 M |
| Other Non-Current Assets | 1.03 M |
| Current Liabilities | 17.9 M |
| Accounts Payable | 5.49 M |
| Short-Term Debt | 4.33 M |
| Other Current Liabilities | 8.11 M |
| Non-Current Liabilities | 29.2 M |
| Long-Term Debt | 29.2 M |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Cash & Cash Equivalents | 225.1 | 140.0 | 74.8 | 268.6 | 43.9 | 44.2 | 3.0 |
| Short Term Investments | 34.6 | 102.6 | 167.9 | 82.6 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 3 K | 79 K | 0.2 | 0 |
| Inventory | 0 | 0 | 0 | 3 K | 0 | 0 | 0 |
| Other Current Assets | 4.1 | 5.4 | 5.0 | 2.8 | 1.4 | 1.3 | 1.9 |
| Total Current Assets | 263.9 | 248.1 | 247.7 | 354.0 | 45.4 | 45.7 | 4.9 |
| PP&E | 32.8 | 36.0 | 38.2 | 1.9 | 2.1 | 2.3 | 2.8 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 1.0 | 1.2 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 1.0 | 0 | 0 | 0 | 2.4 | 98 K | 0.1 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 297.7 | 285.1 | 287.0 | 355.9 | 49.9 | 48.1 | 7.8 |
| LIABILITIES | |||||||
| Accounts Payable | 5.5 | 7.4 | 11.2 | 3.7 | 2.4 | 1.3 | 1.5 |
| Short Term Debt | 4.3 | 2.6 | 2.4 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 8.1 | 12.3 | 8.2 | 6.9 | 2.6 | 2.1 | 1.4 |
| Total Current Liabilities | 17.9 | 22.4 | 21.7 | 10.6 | 4.9 | 3.3 | 2.9 |
| Long Term Debt | 29.2 | 31.5 | 33.4 | 0 | 0 | 107.2 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 1.0 | 1.4 | (100.3) | 51.1 |
| Total Liabilities | 47.1 | 53.9 | 55.1 | 11.7 | 6.4 | 10.3 | 54.0 |
| EQUITY | |||||||
| Common Stock | 78 K | 48 K | 39 K | 38 K | 4 K | 4 K | 3 K |
| Retained Earnings | (572.5) | (438.3) | (296.3) | (166.0) | (102.6) | (65.4) | (47.1) |
| Other Accumulative Comprehensive Income/Loss | 52 K | (0.4) | (0.2) | 77 K | 80 K | 66 K | 26 K |
| Total Equity | 250.6 | 231.2 | 231.9 | 344.3 | 43.5 | 37.9 | (46.2) |
| Total Liabilities and Equity | 297.7 | 285.1 | 287.0 | 355.9 | 49.9 | 48.1 | 7.8 |
| SHARES OUTSTANDING | |||||||
| Common Shares Outstanding | 75.7 | 54.7 | 38.3 | 17.0 | 38.2 | 11.5 | 38.2 |